XML 84 R70.htm IDEA: XBRL DOCUMENT v3.10.0.1
Manufacturing Facility in Guangzhou (Details)
¥ in Thousands, $ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2018
USD ($)
Apr. 04, 2018
CNY (¥)
May 04, 2017
CNY (¥)
Apr. 14, 2017
CNY (¥)
Apr. 13, 2017
CNY (¥)
Mar. 07, 2017
CNY (¥)
Asset
Dec. 31, 2017
USD ($)
Jun. 30, 2017
USD ($)
Apr. 04, 2018
USD ($)
Dec. 31, 2016
USD ($)
Organization                    
Capital contribution from noncontrolling interest | $               $ 14,527    
Cash, cash equivalents and restricted cash | $ $ 470,011           $ 239,602 $ 261,006   $ 87,514
BeiGene Biologics Co., Ltd. (“BeiGene Biologics”)                    
Organization                    
Capital contribution from noncontrolling interest       ¥ 100,000            
GET's equity interest in BeiGene Biologics (as a percent) 5.00%         5.00%        
Cash, cash equivalents and restricted cash | $ $ 145,279                  
Shareholder Loan | Convertible Debt | Investor                    
Organization                    
Face amount       900,000   ¥ 900,000        
Shareholder loan       ¥ 900,000            
Debt instrument term (in years)       72 months            
Long Term Bank Loan April 4, 2018 | Loans Payable                    
Organization                    
Face amount   ¥ 580,000             $ 87,652  
Debt instrument term (in years)   9 years                
Long-term debt | $ $ 42,315                  
BeiGene Biologics Co., Ltd. (“BeiGene Biologics”)                    
Organization                    
Ownership percentage (as a percent) 95.00%                  
BeiGene Biologics Co., Ltd. (“BeiGene Biologics”) | BeiGene (Hong Kong) Co., Limited.(“BeiGene HK”)                    
Organization                    
Cash capital contribution, agreed amount           ¥ 200,000        
Minimum number of biologics assets to be contributed | Asset           1        
Ownership percentage (as a percent)           95.00% 95.00%      
Cash capital contribution     ¥ 2,415   ¥ 137,830          
BeiGene Biologics Co., Ltd. (“BeiGene Biologics”) | GET                    
Organization                    
Cash capital contribution, agreed amount           ¥ 100,000        
BeiGene (Shanghai) Co., Ltd. (“BeiGene (Shanghai)”)                    
Organization                    
Ownership percentage (as a percent) 95.00%                  
BeiGene (Shanghai) Co., Ltd. (“BeiGene (Shanghai)”) | BeiGene (Hong Kong) Co., Limited.(“BeiGene HK”)                    
Organization                    
Ownership percentage (as a percent)             95.00%      
BeiGene (Shanghai) Co., Ltd. (“BeiGene (Shanghai)”) | BeiGene Biologics Co., Ltd. (“BeiGene Biologics”)                    
Organization                    
Ownership percentage (as a percent)             100.00%